Navigation Links
Studies Evaluate Thyroid Treatment During Pregnancy

Efforts in U.S. and Europe are testing effects on women and their offspring,,

FRIDAY, Sept. 25 (HealthDay News) -- Thyroid problems in pregnant women can cause serious consequences in both mothers and children, says an expert familiar with ongoing research into treatments.

An update on clinical trials was to be presented Friday at the annual meeting of the American Thyroid Association, in Palm Beach, Fla.

"Detection and management of thyroid dysfunction during pregnancy is important for many reasons," Dr. Alex Stagnaro-Green, senior associate dean at the Touro University College of Medicine in New Jersey, said in a news release from the association. "For pregnant women with hypothyroidism, there is an increased risk for miscarriage, an increased preterm delivery, an increased risk for decreased IQ and visual motor defects for their offspring."

Stagnaro-Green said that researchers at the U.S. National Institute of Child Health and Human Development are conducting a randomized trial of thyroid drug therapy for pregnant women with hypothyroidism (insufficient production of thyroid hormone) or hypothyroxinemia (abnormally low concentrations of the hormone thyroxine in the blood).

The main goal of the study is to determine if thyroxine treatment in pregnant women is associated with improved intellectual function in their children at age 5. The researchers also want to find out whether thyroxine treatment affects fetal growth, preterm birth or preeclampsia.

"Newborn follow-ups are scheduled at 12, 24 and 36 months and at ages 4 and 5 years," Stagnaro-Green said.

A similar trial being carried out in Britain and Italy -- the Controlled Antenatal Thyroid Screening Study -- is investigating the effect of thyroid treatment on children's intellectual function at age 3.

About one in eight women will develop a thyroid disorder at some point in her life, according to the American Thyroid Association. Women are five to eight times more likely than men to have thyroid problems. Pregnant women with undiagnosed or inadequately treated hypothyroidism are at increased risk for miscarriage and preterm delivery, and their children face a greater risk for severe developmental problems.

The thyroid gland, which is located in the middle of the lower neck, regulates the body's metabolism and affects such body functions as energy level and heart rate. The hormone produced by the thyroid influences every cell, tissue and organ in the body.

About 20 million people in the United States have some form of thyroid disease, and more than 12 percent of the U.S. population will develop a thyroid condition during their lifetime, the association says. Most thyroid diseases are lifelong conditions that can be managed with medical attention.

Up to 60 percent of people with thyroid disease don't know they have the condition. Undiagnosed thyroid disease can put people at risk for serious problems, such as cardiovascular disease, osteoporosis and infertility.

Hypothyroidism occurs when the thyroid does not produce enough thyroid hormone. Symptoms include depression, extreme fatigue, forgetfulness and some weight gain. Too much thyroid hormone production is called hyperthyroidism, and its symptoms include irritability, nervousness, muscle weakness, weight loss, sleep disturbances, eye irritation and vision problems.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about pregnancy and thyroid disease.

-- Robert Preidt

SOURCE: American Thyroid Association, news release, Sept. 23, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Studies Find PSA Screening Unreliable
2. Fructose Boosts Blood Pressure, Studies Find
3. ACP launches ethics case studies series on MedscapeCME
4. Kayentis, the Leading Provider of the Unique "Paper-Based e-Trial" Solution, has been Retained for Six New Clinical Studies in the US Market
5. MedWaves, Inc. Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation-Ablation System for Treatment of Tumors in Liver and Lung
6. Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34 Congress
7. One Dose of Swine Flu Vaccine Offers Protection: Studies
8. NIBIB scientists increase imaging efficiency in cell structure studies
9. FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
10. Studies in animals suggest 2009 H1N1 virus may have biological advantage over seasonal influenza
11. 2 Independent Studies Released on the Effectiveness of Prostate Cancer Treatment
Post Your Comments:
Related Image:
Studies Evaluate Thyroid Treatment During Pregnancy
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: